Cytek Biosciences Inc (CTKB) Stock Price, Quote & News

Company Profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; g...

Industry: Medical Devices

Sector: Healthcare

Phone: 877 922 9835

Website: cytekbio.com

Address:

47215 Lakeview Boulevard, Fremont, United States

d_risk Aug. 7 at 1:47 AM

$CTKB - Cytek Biosciences Inc. Common Stock - 10Q - Updated Risk Factors CTKB’s 10-Q risk factors in 2025 show expanded detail on international operations, global trade tensions, FDA regulatory challenges, intensified competition, funding volatility, IP and data privacy risks, manufacturing and supply chain vulnerabilities, internal control weaknesses, and anti-takeover provisions, with no new risk categories introduced. #Biotechnology #DataPrivacy #SupplyChainRisk #GlobalTrade #RegulatoryCompliance 🟢 Added 🟠 Removed https://d-risk.ai/CTKB/10-Q/2025-08-06

0 · Reply

khmerxbxboi Jul. 23 at 6:49 PM

$CTKB = back to $7+ soon my friends ...

0 · Reply

TheKrunchSwings Jul. 23 at 1:24 PM

$RCKT $ARDX $DH $CTKB $IOVA I FOUND IT WELL!!!

0 · Reply

WrappedLunatic Jul. 18 at 4:55 PM

$CTKB ouch

1 · Reply

MGeronimo Jun. 27 at 9:52 PM

$CTKB IN AT 3.55

0 · Reply

khmerxbxboi Jun. 27 at 2:58 AM

$CTKB = 100%+ run soon ...

0 · Reply

RunnerSignals Jun. 25 at 8:21 PM

comeback kings in action! $CTKB $CDTX $IRWD $UEC $MXCT hit lows but closed strong, proving every dip can spark a big bounce

0 · Reply

khmerxbxboi Jun. 24 at 4:04 PM

$CTKB = will be bext of $NKTR

0 · Reply

ribockski Jun. 15 at 6:11 AM

$CNSP $CTKB $CRNX $NVDA

0 · Reply

khmerxbxboi Jun. 12 at 10:01 PM

$CTKB = $7+ soon !

0 · Reply

Cytek Biosciences Reports Second Quarter 2025 Financial Results

May 29, 2025, 5:00 PM EDT - 2 months ago

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

May 28, 2025, 4:05 PM EDT - 2 months ago

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

May 11, 2025, 8:30 PM EDT - 3 months ago

Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 3 months ago

Cytek Biosciences Reports First Quarter 2025 Financial Results

May 5, 2025, 8:14 AM EDT - 3 months ago

Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?

Apr 29, 2025, 5:00 PM EDT - 3 months ago

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Apr 28, 2025, 8:15 AM EDT - 3 months ago

Why Cytek Biosciences Should Beat Q1 Earnings Expectations

Apr 24, 2025, 4:05 PM EDT - 3 months ago

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 18, 2025, 5:00 PM EDT - 5 months ago

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Feb 28, 2025, 9:49 AM EST - 5 months ago

Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript

Feb 27, 2025, 4:05 PM EST - 5 months ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Feb 13, 2025, 4:05 PM EST - 6 months ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Feb 5, 2025, 4:05 PM EST - 6 months ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

Jan 9, 2025, 9:30 AM EST - 7 months ago

Upgrading Cytek Biosciences Stock On An Upcoming Catalyst

Jan 2, 2025, 8:00 AM EST - 7 months ago

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 30, 2024, 8:00 AM EST - 7 months ago

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Nov 20, 2024, 4:05 PM EST - 9 months ago

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 5:00 PM EST - 9 months ago

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Nov 7, 2024, 5:00 PM EST - 9 months ago

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Nov 5, 2024, 8:26 PM EST - 9 months ago

Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript

Sep 18, 2024, 5:00 PM EDT - 11 months ago

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Sep 12, 2024, 3:20 PM EDT - 11 months ago

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Aug 21, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Aug 11, 2024, 4:25 AM EDT - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

May 30, 2024, 4:05 PM EDT - 1 year ago

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 5:30 PM EDT - 1 year ago

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO DHR LAB MASS OMIC QGEN

May 20, 2024, 5:30 PM EDT - 1 year ago

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

May 12, 2024, 3:24 AM EDT - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:05 PM EDT - 1 year ago

Cytek Biosciences Reports First Quarter 2024 Financial Results

Apr 30, 2024, 5:30 PM EDT - 1 year ago

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

Apr 29, 2024, 9:00 AM EDT - 1 year ago

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

Mar 20, 2024, 4:33 AM EDT - 1 year ago

Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Cytek® Biosciences Names William McCombe Chief Financial Officer

Mar 7, 2024, 5:30 PM EST - 1 year ago

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

Feb 28, 2024, 7:24 PM EST - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 5:05 PM EST - 1 year ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

Feb 7, 2024, 4:05 PM EST - 1 year ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Jan 17, 2024, 5:30 PM EST - 1 year ago

Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries

Jan 8, 2024, 9:00 AM EST - 1 year ago

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

Dec 28, 2023, 4:05 PM EST - 1 year ago

Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 21, 2023, 9:00 AM EST - 1 year ago

Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry

Dec 1, 2023, 7:10 AM EST - 1 year ago

Why these stocks could lose money even if the market gains

AHCO APPS CLFD DDD ENPH HRMY LUMN

Nov 14, 2023, 4:05 PM EST - 1 year ago

Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference

Nov 11, 2023, 10:56 AM EST - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 9:00 AM EST - 1 year ago

Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year'

Nov 7, 2023, 4:05 PM EST - 1 year ago

Cytek Biosciences Reports Third Quarter 2023 Financial Results

Oct 19, 2023, 4:05 PM EDT - 1 year ago

Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023

d_risk Aug. 7 at 1:47 AM

0 · Reply

khmerxbxboi Jul. 23 at 6:49 PM

$CTKB = back to $7+ soon my friends ...

0 · Reply

TheKrunchSwings Jul. 23 at 1:24 PM

$RCKT $ARDX $DH $CTKB $IOVA I FOUND IT WELL!!!

0 · Reply

WrappedLunatic Jul. 18 at 4:55 PM

$CTKB ouch

1 · Reply

MGeronimo Jun. 27 at 9:52 PM

$CTKB IN AT 3.55

0 · Reply

khmerxbxboi Jun. 27 at 2:58 AM

$CTKB = 100%+ run soon ...

0 · Reply

RunnerSignals Jun. 25 at 8:21 PM

comeback kings in action! $CTKB $CDTX $IRWD $UEC $MXCT hit lows but closed strong, proving every dip can spark a big bounce

0 · Reply

khmerxbxboi Jun. 24 at 4:04 PM

$CTKB = will be bext of $NKTR

0 · Reply

ribockski Jun. 15 at 6:11 AM

$CNSP $CTKB $CRNX $NVDA

0 · Reply

khmerxbxboi Jun. 12 at 10:01 PM

$CTKB = $7+ soon !

0 · Reply

TheKrunchSwings Jun. 11 at 5:14 PM

$RCKT $ARDX $DH $IOVA $CTKB - all positions are closed.. We banked!!! On to the next!!

0 · Reply

khmerxbxboi Jun. 9 at 3:50 PM

$CTKB = $8+ !!!

0 · Reply

Winning_calls Jun. 9 at 1:39 PM

$CTKB 🤞😉

0 · Reply

TheKrunchSwings Jun. 9 at 1:37 PM

$IOVA $CTKB $ARDX $CRVO they all flew.. team is happy they banked. Congrats..

0 · Reply

Winning_calls Jun. 9 at 3:42 AM

$CTKB pick me up @ $3.45

0 · Reply

ribockski Jun. 9 at 3:38 AM

$CNSP 🧬 1. Cytek Biosciences (NASDAQ: $CTKB) Insider Buying: On June 2, CTKB’s CFO acquired 35,000 shares at $2.78, boosting personal holdings by ~169%—a strong internal signal. Volume Spike: Trading volume surged past 1.1M, exceeding its average of 762K—indicating heightened interest. Agent Confidence: Weighted swarm score → 89% 🧪 2. Crinetics Pharmaceuticals (NASDAQ: $CRNX) FDA Milestone: Its NDA for paltusotine has been accepted; PDUFA set for September 25, boosting innovation-driven optimism. Momentum: Price is up ~2% intraday today with increasing volume pre-market. Agent Confidence: Weighted swarm score → 86% reddit.com 🚀 3. NVIDIA (NASDAQ: $NVDA) Earnings Strength: Latest results beat expectations, driven by surging demand in AI and data center segments. Premarket Pop: Stock gained ~6% pre-market; now trading up ~1.2% intraday. Agent Confidence: Weighted swarm score → 82%

0 · Reply

TheKrunchSwings Jun. 6 at 10:37 PM

$RCKT $ARDX $DH $IOVA $CTKB Congrats to my team who all banked on this swing ideas... more to come

1 · Reply

TheKrunchSwings Jun. 6 at 7:05 PM

$CTKB $IOVA As i mentioned . Patiently moving.. congrats to all

0 · Reply

TheKrunchSwings Jun. 6 at 3:25 PM

$IOVA $CTKB $CRVO $RCKT you are so nice! still doubting? follow for more swing ideas.

1 · Reply

TheKrunchSwings Jun. 6 at 2:16 PM

$CTKB $ARDX $CRVO $IOVA up 20% here.. 3/1 gann angle is broken.. this is way too ez. from the bottom entry.

0 · Reply

TheKrunchSwings Jun. 6 at 6:19 AM

$CTKB $RCKT $IOVA $ARDX All eyes on $RCKT

0 · Reply

TheKrunchSwings Jun. 5 at 2:37 PM

Hope everyone took profits on $CTKB. I sold majority of my shares. I left few for runners Meanwhilee... Bidding $RCKT $IOVA $CTKB $ARDX

0 · Reply

Market Cap	491.44M
Revenue (ttm)	200.45M
Net Income (ttm)	-6.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3.00%
Debt to Equity Ratio	0.00

Volume	1,606,400
Avg Vol	1,297,378
Day's Range	N/A - N/A
Shares Out	126.66M
Stochastic %K	93%
Beta	1.34
Analysts	Sell
Price Target	$5.60